Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
2.930
-0.040 (-1.35%)
Aug 14, 2025, 2:11 PM - Market open
Jasper Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 39.51 | 71.64 | 86.89 | 38.25 | 84.7 | 19.84 | Upgrade
|
| Cash & Short-Term Investments | 39.51 | 71.64 | 86.89 | 38.25 | 84.7 | 19.84 | Upgrade
|
| Cash Growth | -63.01% | -17.55% | 127.16% | -54.84% | 326.96% | -26.97% | Upgrade
|
| Other Receivables | - | - | 0.25 | 0.91 | 0.55 | 0.6 | Upgrade
|
| Receivables | - | - | 0.25 | 0.91 | 0.55 | 0.6 | Upgrade
|
| Prepaid Expenses | 3.46 | 1.57 | 1.19 | 1.61 | 2.29 | 0.04 | Upgrade
|
| Other Current Assets | - | 2.6 | 0.62 | 0.96 | 0.29 | 0.2 | Upgrade
|
| Total Current Assets | 42.97 | 75.81 | 88.94 | 41.73 | 87.83 | 20.69 | Upgrade
|
| Property, Plant & Equipment | 2.89 | 2.85 | 4.19 | 5.45 | 4.83 | 2.03 | Upgrade
|
| Other Long-Term Assets | 0.61 | 1.24 | 1.76 | 1.18 | 0.99 | 0.64 | Upgrade
|
| Total Assets | 46.47 | 79.9 | 94.89 | 48.36 | 93.65 | 23.36 | Upgrade
|
| Accounts Payable | 8.03 | 4.03 | 4.15 | 1.77 | 3.92 | 1.42 | Upgrade
|
| Accrued Expenses | 10.51 | 9.52 | 6.94 | 4.24 | 2.81 | 2.05 | Upgrade
|
| Current Portion of Leases | 1.95 | 1.09 | 0.97 | 0.87 | 0.51 | - | Upgrade
|
| Other Current Liabilities | - | 0.6 | 0.32 | 0.19 | 0.79 | 0.55 | Upgrade
|
| Total Current Liabilities | 20.5 | 15.24 | 12.37 | 7.07 | 8.02 | 4.01 | Upgrade
|
| Long-Term Leases | 0.2 | 0.72 | 1.81 | 2.79 | 2.38 | 1.62 | Upgrade
|
| Long-Term Unearned Revenue | - | 2.26 | 2.26 | 2.26 | 0.6 | 0.6 | Upgrade
|
| Other Long-Term Liabilities | 2.26 | - | - | 0.26 | 13.14 | 8.41 | Upgrade
|
| Total Liabilities | 22.97 | 18.23 | 16.45 | 12.37 | 24.14 | 14.65 | Upgrade
|
| Common Stock | 0 | 0 | 0 | - | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 312.33 | 302.54 | 248.04 | 141.12 | 136.96 | 1.68 | Upgrade
|
| Retained Earnings | -288.83 | -240.87 | -169.6 | -105.14 | -67.45 | -36.81 | Upgrade
|
| Total Common Equity | 23.5 | 61.67 | 78.44 | 35.99 | 69.52 | -35.13 | Upgrade
|
| Shareholders' Equity | 23.5 | 61.67 | 78.44 | 35.99 | 69.52 | 8.71 | Upgrade
|
| Total Liabilities & Equity | 46.47 | 79.9 | 94.89 | 48.36 | 93.65 | 23.36 | Upgrade
|
| Total Debt | 2.16 | 1.81 | 2.79 | 3.65 | 2.89 | 1.62 | Upgrade
|
| Net Cash (Debt) | 37.36 | 69.82 | 84.1 | 34.6 | 81.82 | 18.21 | Upgrade
|
| Net Cash Growth | -64.25% | -16.98% | 143.07% | -57.71% | 349.19% | -32.95% | Upgrade
|
| Net Cash Per Share | 2.47 | 4.79 | 8.06 | 9.48 | 71.81 | 105.29 | Upgrade
|
| Filing Date Shares Outstanding | 16.25 | 15.02 | 15.06 | 10.94 | 4.95 | 10.16 | Upgrade
|
| Total Common Shares Outstanding | 16.22 | 15.02 | 11.16 | 4.62 | 4.95 | 9.81 | Upgrade
|
| Working Capital | 22.47 | 60.57 | 76.56 | 34.67 | 79.81 | 16.67 | Upgrade
|
| Book Value Per Share | 1.45 | 4.11 | 7.03 | 7.78 | 14.04 | -3.58 | Upgrade
|
| Tangible Book Value | 23.5 | 61.67 | 78.44 | 35.99 | 69.52 | -35.13 | Upgrade
|
| Tangible Book Value Per Share | 1.45 | 4.11 | 7.03 | 7.78 | 14.04 | -3.58 | Upgrade
|
| Machinery | - | 2.88 | 2.62 | 2.35 | 1.92 | 0.44 | Upgrade
|
| Leasehold Improvements | - | 2.71 | 2.48 | 2.48 | 2.06 | 0.26 | Upgrade
|
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.